These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


319 related items for PubMed ID: 26438200

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease.
    Beltrán B, Iborra M, Sáez-González E, Marqués-Miñana MR, Moret I, Cerrillo E, Tortosa L, Bastida G, Hinojosa J, Poveda-Andrés JL, Nos P.
    Dig Dis; 2019; 37(2):108-115. PubMed ID: 30149385
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Implications of Infliximab Treatment Failure and Influence of Personalized Treatment on Patient-reported Health-related Quality of Life and Productivity Outcomes in Crohn's Disease.
    Steenholdt C, Brynskov J, Thomsen OØ, Munck LK, Christensen LA, Pedersen G, Kjeldsen J, Ainsworth MA.
    J Crohns Colitis; 2015 Nov; 9(11):1032-42. PubMed ID: 26245216
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Infliximab for the treatment of Crohn's disease: efficacy and safety in a Chinese single-center retrospective study.
    Zhou Y, He H, Wang P, Zhang T, Lin M, Wang H, Nie Y, Chen Y.
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1270-5. PubMed ID: 26275085
    [Abstract] [Full Text] [Related]

  • 14. Long-term risk of infection in patients with Crohn's disease on anti-TNF treatment: A prospective single-center cohort study in China.
    Li Y, Shu HJ, Lu H, Yang H, Li J, Tan B, Qian JM.
    J Dig Dis; 2017 Jul; 18(7):388-394. PubMed ID: 28644565
    [Abstract] [Full Text] [Related]

  • 15. High-dose infliximab therapy in Crohn's disease: clinical experience, safety, and efficacy.
    Hendler SA, Cohen BL, Colombel JF, Sands BE, Mayer L, Agarwal S.
    J Crohns Colitis; 2015 Mar; 9(3):266-75. PubMed ID: 25540149
    [Abstract] [Full Text] [Related]

  • 16. [A comparative study of induction of remission and cost-effectiveness of enteral nutrition versus infliximab in moderate-to-severe Crohn's disease].
    Zhu WM, Zuo LG, Li Y, Cao L, Zhang W, Gu YF, Xu M, Li N, Li JS.
    Zhonghua Nei Ke Za Zhi; 2013 Sep; 52(9):721-5. PubMed ID: 24314158
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Changes in serum trough levels of infliximab during treatment intensification but not in anti-infliximab antibody detection are associated with clinical outcomes after therapeutic failure in Crohn's disease.
    Steenholdt C, Bendtzen K, Brynskov J, Thomsen OØ, Munck LK, Christensen LA, Pedersen G, Kjeldsen J, Ainsworth MA.
    J Crohns Colitis; 2015 Mar; 9(3):238-45. PubMed ID: 25576753
    [Abstract] [Full Text] [Related]

  • 19. Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn's Disease Is Determined by Their Concentration.
    Edlund H, Steenholdt C, Ainsworth MA, Goebgen E, Brynskov J, Thomsen OØ, Huisinga W, Kloft C.
    AAPS J; 2017 Jan; 19(1):223-233. PubMed ID: 27739011
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.
    Peeters H, Louis E, Baert F, Dewit O, Coche JC, Ferrante M, Lambrecht G, Colard A, Van Gossum A, Bossuyt P, Moreels T, Vander Cruyssen B, Gils A, De Vos M.
    Acta Gastroenterol Belg; 2018 Jan; 81(1):15-21. PubMed ID: 29562373
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.